Revvity | PKI - Interest Expense On Debt


Revvity reported $22.99M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Agilent USD 25M 0 Mar/2026
Align Technology USD 6.93M 9.11M Mar/2026
Bio Techne USD 3.6M 1.19M Jun/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Celltrion KRW 19B 1.96B Jun/2025
Charles River Laboratories USD 30.34M 3.6M Jun/2026
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
Danaher USD 107M 44M Jun/2026
Dentsply International USD 22M 2M Jun/2026
Deva Holding AS TRY 272.53M 69.04M Sep/2023
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 60M 0 Jun/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Illumina USD 24M 2M Mar/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
IQVIA Holdings USD 197M 5M Jun/2026
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Laboratory Of America USD 61.1M 6M Jun/2026
Medical Developments International AUD 18K 3K Jun/2025
Mesa Laboratories USD 3.02M 180K Sep/2024
Mettler Toledo International USD 17.25M 239K Jun/2026
Myriad Genetics USD 4.4M 600K Dec/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
OraSure Technologies 1.67M 1.13M Dec/2025
Organigram Holdings CAD 179K 127K Mar/2025
Ovoca Bio EUR 7K 6K Jun/2022
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Qiagen NV USD 10.02M 1.03M Jun/2026
Quest Diagnostics USD 69M 2M Sep/2025
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.66M 85K Jun/2026
Revvity USD 22.99M 1.73M Jun/2026
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Thermo Fisher Scientific USD 354M 11M Mar/2026
Tilray USD 6.7M 2.73M Jun/2025
Waters USD 55M 13M Jun/2026
Zealand Pharma A/S 7.07M 74K Dec/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025